SUMMARY A family study was performed to determine whether the hypertriglyceridaemia associated with gout is present in families of gout patients or due to the life style of the patient himself. The study revealed the expected hypertriglyceridaemia in gout patients; this was reflected by elevated serum levels of prebetalipoproteins and with reduction in the proportion of beta-lipoprotein. None of these abnormalities were seen in the first-degree relatives. Furthermore, the proportion of high-density lipoproteins was not significantly raised in gout patients.
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To determine whether the hypertriglyceridaemia of gout patients occurs in their families or is simply the result of the life style of these obese, often alcoholdrinking patients who frequently originate from higher social classes' a family study was designed to measure lipid and uric acid levels in the blood of gout patients and their first-degree relatives and to compare them with those found in controls of the same age and sex.
Patients and methods
Pedigrees were constructed for 169 male and 11 female primary gout patients with details of age and whereabouts of all living, first-degree relatives. The patients had been diagnosed by generally accepted clinical criteria; many of them were receiving treatment for hyperuricaemia at the time of the study. Lipid and uric acid data for gout patients, first-degree relatives, and expected values for controls at the same mean age are given in traditional units in Tables  la and lb. The means and standard deviations of variables from gouty index patients and relatives when compared with controls are also expressed in standard deviation units in Table 2 to eliminate the variables of age and sex. The statistical significance of differences between data from gout patients, relatives, and controls is indicated. Table 2 shows that triglyceride levels in gout patients were found to be significantly higher than in controls (p<0001). These changes were, predictably, reflected by changes in the proportion of pre-,8-lipoprotein, which was also significantly higher in gout patients than in controls (p<0001).
There was a significant reduction in the proportion of ,3-lipoprotein in gout patients when compared with controls (p<0001). Table 3 shows that triglyceride and pre-,f-lipoprotein levels in gout patients were significantly higher than in relatives (p<0001) with a significant reduction in the proportion of ,8-lipoprotein (OOl>p>O-OOl). Table 3 shows a small but significant reduction in the proportion of 8-lipoprotein in relatives when Table 3 also shows a marginal increase in the proportion of a-lipoprotein in relatives when compared with both gout patients and controls (0-05>p>001), but there was no significant difference between the a-lipoprotein proportions in gout patients and controls. There was no significant difference between cholesterol levels in gout patients and controls or between gout patients and relatives, but both Tables  2 and 3 show that there was a marginal increase in cholesterol levels in relatives when compared with controls (005>p>001).
As shown in Table 3 , uric acid levels in male, gouty index patients were significantly higher than in controls or relatives (p<0001), despite the fact that many of them were on urate-lowering drugs. Separate analysis of female index patients must be assessed with caution in view of the small numbers concerned. Table 2 shows that the mean uric acid level in relatives was slightly greater than in controls, but this difference was very small and did not approach the significant elevation found in the study of Hauge and Harvald.8 The families of 35 gout patients who were found to have lipid levels (triglyceride and/or cholesterol) above the 95th centile were assessed to determine whether they constituted a particular subgroup in the family study.
First-degree relatives of hyperlipidaemic, gouty index patients had raised cholesterol levels when compared with controls (males OO5>p>0025; females 002>p>0-01). There were no elevations in triglyceride levels among these relatives.
Weights were measured in gout patients, relatives, and controls. There were too few female gout patients for analysis, but the weight data presented in Tables 4 and 5 were analysed and showed that male, gout patients were significantly heavier than male Family study oflipid and purine levels in gout patients 255 The hypercholesterolaemia in first-degree relatives of hyperlipidaemic gouty index patients is best explained by polygenic inheritance in the same way as first-degree relatives of tall index patients tend to be taller than average. Since the hyperlipidaemia was a hypercholesterolaemia (and not a hypertriglyceridaemia such as occurs in association with gout) it was probably a finding which is unrelated to hyperuricaemia or gout itself.
Unaffected relatives of gout patients have been reported to show an increased serum level of uric acid, which is thought to be determined by polygenetic factors.8
The results of this family study reveal hyperpre-83-lipoproteinaemia in gout patients as a whole with reduction in ,8-lipoprotein. These abnormalities were not seen in first-degree relatives, suggesting that the hypertriglyceridaemia associated with gout is not present in the families of gout patients but is rather due to factors in the life style of the patients.
